Menstrual and reproductive factors and exogenous hormone use and risk of transitional cell bladder cancer in postmenopausal women

European Journal of Cancer Prevention

Volumn 22, Issue 5, 2013, Pages 409-416

  Kabat, Geoffrey C ^a   Kim, Mimi Y ^a   Luo, Juhua ^c   Hou, Lifang ^d   Cetnar, Jeremy ^e   Wactawski Wende, Jean ^b   Rohan, Thomas E ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Bladder cancer; Cohort studies; Hormone therapy; Reproductive factors

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER RISK; COHORT ANALYSIS; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MENSTRUATION; MULTICENTER STUDY; NULLIPARA; OBSERVATIONAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCTIVE HISTORY; SPONTANEOUS ABORTION; TRANSITIONAL CELL CARCINOMA;

AGED; CARCINOMA, TRANSITIONAL CELL; CONTRACEPTIVES, ORAL, HORMONAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; HORMONES; HUMANS; MENSTRUATION; MIDDLE AGED; POSTMENOPAUSE; REPRODUCTIVE HISTORY; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84882267589     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32835f3ba3     Document Type: Article

References (40)

1. Aikawa K, Sugino T, Matsumoto S, Chichester P,Whitbeck C, Levin RM (2003). The effect of ovariectomy and estradiol on rabbit bladder smooth muscle contraction and morphology. J Urol 170:634-637
2. American Cancer Society (2009). Cancer facts and figures 2009. Atlanta: American Cancer Society
3. Bertram JS, Craig AW (1972). Specific induction of bladder cancer in mice by butyl-(4-hydroxybutyl)-nitrosamine and the effects of hormonal modifications on the sex difference in response. Eur J Cancer 8:587-594
4. Cantor KP, Lynch CF, Johnson D (1992). Bladder cancer, parity, and age at first birth. Cancer Causes Control 3:57-62
5. Cantwell MM, Lacey JV Jr, Schairer C, Schatzkin A, Michaud DS (2006). Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study. Int J Cancer 119:2398-2401
6. Curb JD, McTiernan A, Heckbert SR, Kooperberg C, Stanford J, Nevitt M, et al. (2003). Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol 13:S122-S128
7. Davis-Dao CA, Henderson KD, Sullivan-Halley J, Ma H,West D, Xiang YB, et al. (2011). Lower risk in parous women suggests that hormonal factors are important in bladder cancer etiology. Cancer Epidemiol Biomarkers Prev 20:1156-1170
8. Dietrich K, Demidenko E, Schned A, Zens MS, Heaney J, Karagas MR (2011). Parity, early menopause and the incidence of bladder cancer in women: A case-control study and meta-Analysis. Eur J Cancer 47:592-599
9. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC (2011). Association between smoking and risk of bladder cancer among men and women. JAMA 306:737-745
10. Gu J, Wu X (2011). Genetic susceptibility to bladder cancer risk and outcome. Per Med 8:365-374
11. Hankinson SE (2005). Endogenous hormones and risk of breast cancer in postmenopausal women. Breast Dis 24:3-15
12. Hextall A (2000). Oestrogens and lower urinary tract function. Maturitas 36:83-92
13. Huang AT, Kogevinas M, Silverman DT, Malats N, Rothman N, Tardon A, et al. (2009). Bladder cancer and reproductive factors among women in Spain. Cancer Causes Control 20:1907-1913
14. Kabat GC, Etgen AM, Rohan TE (2010). Do steroid hormones play a role in the etiology of glioma? Cancer Epidemiol Biomarkers Prev 19:2421-2427
15. Kelsey JL, Gammon MD, John EM (1993). Reproductive factors and breast cancer. In: Kelsey JL, editor. Epidemiol Rev. 15:pp. 36-47
16. Kiemeney LA, Grotenhuis AJ, Vermeulen SH, Wu X (2009). Genome-wide association studies in bladder cancer: First results and potential relevance. Curr Opin Urol 19:540-546
17. Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M (2003). The Women's Health Initiative Observational Study: Baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 13:S107-S121
18. La Vecchia C, Negri E, Franceschi S, Parazzini F (1993). Long-Term impact of reproductive factors on cancer risk. Int J Cancer 53:215-219
19. La Vecchia C, Ron E, Franceschi S, Dal Maso L, Mark SD, Chatenoud L, et al. (1999). A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control 10:157-166
20. McGrath M, Michaud DS, De Vivo I (2006). Hormonal and reproductive factors and the risk of bladder cancer in women. Am J Epidemiol 163:236-244
21. Michaud DS, Gallo V, Schlehofer B, Tjonneland A, Olsen A, Overvad K, et al. (2010). Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer Epidemiol Biomarkers Prev 19:2562-2569
22. Miyamoto H, Yang Z, Chen YT, Ishiguro H, Uemura H, Kubota Y, et al. (2007). Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst 99:558-568
23. Negri E, Dal Maso L, Ron E, La Vecchia C, Mark SD, Preston-Martin S, et al. (1999). A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control 10:143-155
24. Noronha RF, Rao BR (1986). Sex hormone receptors in localized and advanced transitional cell carcinoma of urinary tract in humans. Urology 28:401-403
25. Pelucchi C, La Vecchia C, Negri E, Dal Maso L, Franceschi S (2002). Smoking and other risk factors for bladder cancer in women. Prev Med 35:114-120
26. Peterson E, De P, Nuttall R (2012). BMI, diet and female reproductive factors as risks for thyroid cancer: A systematic review. PLoS ONE 7:e29177
27. Prizment AE, Anderson KE, Harlow BL, Folsom AR (2007). Reproductive risk factors for incident bladder cancer: IowaWomen's Health Study. Int J Cancer 120:1093-1098
28. Reid LM, Leav I, Kwan PW, Russell P, Merk FB (1984). Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice. Cancer Res 44:4560-4573
29. Rizk DE, Raaschou T, Mason N, Berg B (2001). Evidence of progesterone receptors in the mucosa of the urinary bladder. Scand J Urol Nephrol 35:305-309
30. Robinson D, Cardozo LD (2003). The role of estrogens in female lower urinary tract dysfunction. Urology 62:45-51
31. Rothman KJ, Greenland S, Lash TL (2008). Modern epidemiology. 3rd ed. Philadelphia: Wolters Kluwer-Lippincott Williams & Wilkins. p. 411
32. Russo J, Balogh GA, Russon IH (2008). Full-Term pregnancy induces a specific genomic signature in the human breast. Cancer Epidemiol Biomarkers Prev 17:51-66
33. Shan Y, Li L, Yan C, Yin F (1998). Expression of estrogen receptors and progesterone receptors in transitional cell carcinoma of bladder. Chin Med J (Engl) 111:191-192
34. Shen SS, Smith CL, Hsieh JT, Yu J, Kim IY, Jian W, et al. (2006). Expression of estrogen receptors-Alpha and -beta in bladder cancer cell lines and human bladder tumor tissue. Cancer 106:2610-2616
35. Silverman DT, Devesa SS, Moore LE, Rothman N (2006). Bladder cancer. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. New York: Oxford University Press. pp. 975-994
36. Tincello DG, Taylor AH, Spurling SM, Bell SC (2009). Receptor isoforms that mediate estrogen and progestagen action in the female lower urinary tract. J Urol 181:1474-1482
37. Tripathi A, Folsom AR, Anderson KE (2002). Risk factors for urinary bladder carcinoma in postmenopausal women. The Iowa Women's Health Study. Cancer 95:2316-2323
38. The Women's Health Initiative Study Group (1998). Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 19:61-109
39. Wolpert BJ, Amr S, Ezzat S, Saleh D, Gouda I, Loay I, et al. (2010). Estrogen exposure and bladder cancer risk in Egyptian women. Maturitas 67:353-357
40. Wu X, Hildebrandt AT, Chang DW (2009). Genome-wide association studies of bladder cancer risk: A field synopsis of progress and potential applications. Cancer Metastasis Rev 28:269-280